FDA declines to review Moderna application for new flu vaccine
US regulators will not review Moderna’s request to license a new, potentially more effective flu shot – even…
US regulators will not review Moderna’s request to license a new, potentially more effective flu shot – even…
Sen. Mark Kelly (D-AZ) speaks after departing federal court on Feb. 3, 2026 in Washington, DC. Heather Diehl…
LONDON — European stocks are expected to open in negative territory as concerns over artificial intelligence and volatility…